Apyx Medical Corporation (NASDAQ: APYX) is a Healthcare company (Medical - Specialties) with a market capitalization of $108M. The Maz Rating grades it against the other companies in its sector.
Apyx Medical Corporation's current Maz Rating and its five factor grades are for members: log in to see them.
At $2.56, Apyx Medical Corporation trades at 1.7x sales and 11.1x book value. Over the last twelve months it generated about $63M of revenue and a net loss of $9M. It runs a gross margin of 34.5%, an operating margin of -5.5% and a net margin of -14.2%. It shows return on equity of -70.8%, return on invested capital of -6.4% and a free cash flow yield of -8.4%. On the balance sheet: a debt-to-equity ratio of 4.13 and a current ratio of 4.95. Over the past 52 weeks the share price ranged from $2.25 to $5.08, with a beta of 1.31.
Apyx Medical Corporation does not currently pay a dividend.
9 Wall Street analyst ratings cover the stock: 8 Buy and 1 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.